v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenue    
Revenue
Total revenue
Cost of goods sold    
Cost of goods sold
Total cost of goods sold
Gross profit
Operating expenses    
Research and development 576,260 552,126
General and administrative 1,480,360 1,413,592
Total operating expenses 2,056,620 1,965,718
Loss from operations (2,056,620) (1,965,718)
Other income (expense), net    
Interest expense, net (1,015) (3,273)
Interest income 40,082 65,197
Total other income (expense), net 39,067 61,924
Net loss (2,017,553) (1,903,794)
Deemed dividend related to warrant exercise price adjustment (16,774)
Net loss attributable to common stockholders $ (2,017,553) $ (1,920,568)
Net loss per common share attributable to common stockholders - basic $ (0.21) $ (0.26)
Net loss per common share attributable to common stockholders - diluted $ (0.21) $ (0.26)
Weighted average number of shares outstanding - basic 9,689,812 7,388,508
Weighted average number of shares outstanding - diluted 9,689,812 7,388,508

Source